RCM
MDCO

Riverhead Capital Management’s Medicines Co MDCO Stock Holding History

Riverhead Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$730K Hold
14,606
– – 0.03% 580
2019
Q2 		$533K Hold
14,606
– – 0.02% 704
2019
Q1 		$408K Hold
14,606
– – 0.02% 799
2018
Q4 		$280K Buy
14,606
+2,300
+19% +$53.5K 0.01% 921
2018
Q3 		$368K Buy
12,306
+3,000
+32% +$113K 0.01% 909
2018
Q2 		$341K Hold
9,306
– – 0.01% 840
2018
Q1 		$307K Hold
9,306
– – 0.01% 868
2017
Q4 		$254K Buy
9,306
+1,300
+16% +$40K 0.01% 966
2017
Q3 		$297K Buy
8,006
+1,046
+15% +$38.6K 0.01% 808
2017
Q2 		$264K Buy
6,960
+2,960
+74% +$132K 0.01% 810
2017
Q1 		$196K Buy
4,000
+500
+14% +$22.8K 0.01% 778
2016
Q4 		$119K Hold
3,500
– – 0.01% 909
2016
Q3 		$132K Sell
3,500
-15,413
-81% -$581K 0.01% 802
2016
Q2 		$1.72M Buy
18,913
+5,263
+39% +$186K 0.06% 328
2016
Q1 		$434K Sell
13,650
-350
-3% -$11.4K 0.01% 942
2015
Q4 		$523K Buy
14,000
+10,400
+289% +$393K 0.01% 877
2015
Q3 		$137K Buy
+3,600
New +$126K ﹤0.01% 900

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Riverhead Capital Management's MDCO Position: Q3 2019 in Review

Riverhead Capital Management held its Medicines Co (MDCO) position steady in Q3 2019 at 14,606 shares worth $730K. The position accounts for 0.03% of the portfolio, ranked #580.

Riverhead Capital Management first reported a position in MDCO in Q3 2015 and has held it in 17 quarters since. The position peaked at $1.72M in Q2 2016. 250 funds tracked by Wall St. Rank hold MDCO as of Q3 2019.

  • Riverhead Capital Management held 14,606 shares of Medicines Co worth $730K as of Q3 2019.
  • Riverhead Capital Management left its Medicines Co share count unchanged in Q3 2019.
  • Medicines Co made up 0.03% of Riverhead Capital Management's portfolio in Q3 2019, its #580 holding.
  • Riverhead Capital Management first reported a position in Medicines Co in Q3 2015 and has held it in 17 quarters since.
  • Riverhead Capital Management's Medicines Co position peaked at $1.72M in Q2 2016.
  • 250 funds tracked by Wall St. Rank held Medicines Co as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.